期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

安赛玛对老年慢性阻塞性肺病患者肺功能改善的临床观察 被引量：2

Clinical study on improvement of lung function in aged patients with COPD by Doxofylline
下载PDF
导出
摘要 目的 :观察安赛玛 (多索茶碱 )对老年慢性阻塞性肺病患者肺功能的影响。方法 :32例老年慢性阻塞性肺病肺功能不良患者口服安赛玛 (0 .4～ 0 .8g/ d)治疗 1个月 ,应用肺功能仪检测其肺功能治疗后改善情况。结果 :治疗后较治疗前肺功能得到明显改善 (P<0 .0 5 )。结论 :安赛玛在有效缓解支气管痉挛的同时 。 Objective:To observe the effects of Doxofylline on lung function in aged patients with chronic obstruction pulmonary disease (COPD).Methods:Thirty two elderly patients with COPD were treated with Doxofylline (0.4~0.8 g) every day for one months.Clinical improvement of lung function was studied with pulmonary function analysis.Results:was improved significantly ( P <0 05) compared with that before. Conclusion: The results prove that Doxofylline treatment can remit bronchodilators and improve lung function in aged patients with COPD.
作者 于振香 钱东华 王晓岩 黄宝辉 夏贵生
机构地区 吉林大学第一医院呼吸科 吉林省第二中医院呼吸科 辽源矿务局总医院
出处 《白求恩医科大学学报》 CAS CSCD 北大核心 2001年第5期532-533,共2页 Journal of Norman Bethune University of Medical Science
关键词 安赛玛 老年人 慢性阻塞性肺病 肺功能 COPD Doxofylline elderly COPD lung function
分类号 R563 [医药卫生—呼吸系统] R974.3 [医药卫生—药品]
  • 相关文献

参考文献3

  • 1[1]Bone RC. Asthma: New erealment will improve disease management[J]. J Clin Pulm Med, 1995,2: 249-251.
  • 2[2]Torphy TJ, Nnedew BJ. Phosphodiesterase inhibitors : New opportunities for the treatment of asthma [J]. Thorax, 1991, 46:512-514.
  • 3[3]Barnes PJ ,Pauwels RA. Theophyline in the management of asthoua :Time for reappraisal? [J]. Eur Respir J, 1994,7: 579-591.

同被引文献58

  • 1张家洪,龚兰,辛得光,王来桂.应用超声显像观察氨茶碱对慢性阻塞性肺病膈肌活动的影响[J].临床内科杂志,1996,13(3):24-25. 被引量：4
  • 2[10]Compton CH, Gubb J, Nieman R, et al. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet,2001,358(9278):265～270
  • 3[15]Di Lorenzo G, Morici G, Drago A,et al. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group. Clin Ther,1998,20(6):1130～1148
  • 4[16]Oren R, Beeri M, Hubert A, et al.Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Arch Intern Med,1997,157(13):1474～1478
  • 5[17]Nakamura A, Kasamatsu N, Hashizume I, et al. Effects of hemoglobin on pulmonary arterial pressure and pulmonary vascular resistance in patients with chronic emphysema. Respiration, 2000,67(5):502～506
  • 6[1]Miravitlles M,Mayordomo C, Artes M,et al.Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice.Respir Med,1999 ,93(3):173～179
  • 7[6]Tsukino M,Nishimura K,Ikeda A,et al.Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Thorax,1998,53(4):269～273
  • 8[7]Dorinsky PM, Reisner C, Ferguson GT,et al. The combination of ipratropium and albutreol optimizes pulmonary function reversibility testing in patients with COPD. Chest, 1999,115(4): 966～971
  • 9[8]Villani F,De Maria P, Ronchi E, et al. Oral doxophylline in patients with chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther,1997 ,35(3):107～111
  • 10[1]Scanlon PD.Connett JE.Waller.A.et al.Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease.The Lung Health Study[J] .Am J Respir Crit Care Med, 2000,161(2 Pt1):381

引证文献2

二级引证文献3

白求恩医科大学学报
2001年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部